Skip to main content

Microbiome Therapeutics Market Projected to Expand US$ 890 Mn by 2025

According to the latest market report published by Persistence Market Research, titled ‘Microbiome Therapeutics Market Potential: Global Pipeline Analysis and Assessment 2018 – 2025’, the global microbiome therapeutics market is expected to exhibit an exponential CAGR of 62.9% during the forecast period 2018–2025.
Persistence Market Research estimates that the global market for microbiome therapeutics is expected to be valued at US$ 10.1 Mn in 2018 and is expected to reach US$ 897.3 Mn by 2025 end. Need for reliable, precise and fast treatment options for certain diseases, such as C. difficile infection (CDI), phenylketonuria, hepatic encephalopathy and multidrug resistant urinary tract infection creates a huge potential for the growth of the microbiome therapeutics market. Breakthrough therapy designation and orphan drug approvals for microbiome therapeutics is expected to accelerate the launch of developmental drugs in the microbiome therapeutics market. A huge pipeline with over 120 candidates in different stages of development further creates the platform for potential growth of the microbiome therapeutics market.
More Than 120 Drugs Are in the Pipeline in the Global Microbiome Therapeutics Market
At present there are no marketed microbiome therapeutics in the global market; however, the first drug is expected to be launched in 2018. The global market is dominated by over 25 companies with more than 120 drugs in the pipeline at different stages of development. However, over 60% of these drugs are in the discovery or preclinical phase, where there is high uncertainty surrounding the success of these molecules to reach the clinical phase and being launched as a new drug molecule. Majority of the pipeline drugs are being developed for gastrointestinal disorders and contribute approximately 28.7% of the total pipeline products.
Research and development in the microbiome industry is prominently dependent on government funding and research grants. Formation of policies and provision of subsidy by various governments encourages research and development activities across various segments of the research including discovery and clinical research. Government initiatives in funding microbiome research is the preliminary factor driving revenue growth of global microbiome therapeutics market. For instance, the U.S. government had allocated US$ 1.6 Bn for microbiome R&D programs in 2016 & 2017.
Global Microbiome Therapeutics Market: Segmentation and Forecast
The market is segmented based on indication and region. On the basis of indication, the market has been segmented into type 2 diabetes, obesity, C. difficile infection and primary hyperoxyurea. C. difficile infection indication segment is expected to contribute the highest market share of over 34% by 2025 end. More number of product approvals for CDI is attributed to a high share of the C. difficile infection segment in the global market.
Human gut is home to over 100 Tn bacteria, containing thousands of different species. Long-term exposure to antibiotics causes dysbiosis in gut microbial composition, which leads to a variety of gastrointestinal disorders including CDI, ulcerative colitis, IBD, bacterial infection and even antibiotic associated diarrhea. Microbiome therapeutics however, present an excellent option for the treatment of CDI and other gastrointestinal disorders, as they are designed to naturally cure dysbiosis and bring the microbiome system back to normal functioning.
Request and Download Sample Report@
https://www.persistencemarketresearch.com/samples/7990
Global Microbiome Therapeutics Market: Regional Forecast
On the basis of region, the market has been segmented into the U.S., Europe, Japan and Rest of the World (RoW). U.S. is estimated to contribute the highest share of over 44% by 2025 end, due to early launch of microbiome therapeutics and high penetration compared to other markets. The market in Japan is expected to witness delayed growth due to the complex regulatory pathways for new biological drugs. The microbiome therapeutics market in the rest of the world is expected to show gradual acceptance of “bug medicine”, Canada being the most lucrative among the rest of the world countries.
Global Microbiome Therapeutics Market: Competitive Landscape
Key players identified in the global microbiome therapeutics market are SERES Therapeutics Inc., Rebiotix Inc., OxThera AB, Immuron Ltd., Microbiome Therapeutics Inc., Ferring B.V., Ritter Pharmaceuticals, LNC Therapeutics, Enterome SA, Synlogic Inc., 4D Pharma Plc. AOBiome LLC, Vedanta Biosciences Inc., ViThera Pharmaceuticals Inc., AvidBiotics, Osel Inc. etc. among others.
Majority of the players in the microbiome therapeutics market are engaged in partnerships and collaborations with established pharmaceutical companies and academic institutes. Small start-up and clinical stage microbiome companies are capitalizing on venture financing to establish microbiome based novel therapeutics in the global market. Despite of decrease in the overall venture capital investments, the microbiome industry has witnessed high VC investments in 2016, and raised approximately to US$ 336 Mn in 2016. Partnerships and research collaborations are another prominent trends identified in global microbiome therapeutics market.
Download and View Report TOC, Figures and Tables @ https://www.persistencemarketresearch.com/market-research/microbiome-therapeutic-market/toc
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com

Labels:

Comments

Post a Comment

Popular posts from this blog

Australia & New Zealand Herbal Supplements Market to Expand US$ 760.9 Mn by 2025

According to the report, titled “ Herbal Supplements Market: Australia & New Zealand Industry Analysis and Forecast, 2017–2025 ,” the market is expected to bring in US$ 434.9 Mn by the end of 2017. In the eight-year forecast period, the herbal supplement revenues in Australia & New Zealand will have soared at an impressive 7.2% CAGR. The region’s rich dietary culture and growing per capita healthcare expenditure will continue to favor the growth of its herbal supplements market. Increasing demand for herbal supplements to strengthen one’s immunity and a sizeable population of baby boomers are two crucial factors driving the sales of herbal supplements in Australia and New Zealand. Balancing diets of the common people continues to be a top priority of governments witnessing an alarming rise in food-related disorders. Some regions are augmenting their staple foods while others are adopting new edible products in their nutritionally deficient diets. On the same lines, the de...
Post a Comment
Read more

Fifth Wheel Coupling Market Projected to Value US$ 700 Mn by 2025

Persistence Market Research presents a new report titled ‘Fifth Wheel Coupling Market: Global Industry Analysis 2012 – 2016 and Forecast 2017 – 2025’ that studies the performance of the global fifth wheel coupling market over an eight year assessment period from 2017 to 2025. The report presents the value and volume forecasts of the global fifth wheel coupling market and provides important insights into the factors driving market growth as well as the factors restricting market growth. As per the assessment of Persistence Market Research, the global fifth wheel coupling market was estimated to be valued at nearly US$ 460 Mn in 2017 and is anticipated to touch a valuation of nearly US$ 700 Mn in 2025 and in the process exhibit a CAGR of 5.4% during the period of forecast 2017-2025. Advanced Material Technology Positively Impacting the Global Fifth Wheel Coupling Market The adoption of advanced material technology in automobile components increases the load capacity as well as st...
Post a Comment
Read more

Building Automation Systems Market Will Amass at 11.1% CAGR by 2026

In reference to a new report published by Persistence Market Research, the global  building automation systems market  will showcase significant growth between 2016 and 2026. Manufacturers of building automation systems are rapidly adopting new regulations set across the globe and they are also lining up new products to meet rising market demand. The Persistence Market Research report titled,  “Building Automation Systems Market: Global Industry Analysis & Forecast, 2016-2026”,  talks in detail about the market psyche and also scrutinizes the market drifts which are expected to impact the future of the global building automation systems market. The global building automation systems market was valued more than US$ 43 Bn in 2015 and is expected to mint better revenue by the end of 2016, reaching approximately US$ 48 Bn. The market will continue its journey towards expansion and the market worth will reach US$ 141.1 Bn towards the end of 2026. The global building...
Post a Comment
Read more